ANTM · Insider Trading
ANTHEM INC COM STK (IN)
Every open-market purchase and sale reported by ANTM officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-13 | Charles Morgan Kendrick JR | EVP & President, Commercial | MIXED | — | −$1.29M |
| 2022-06-07 | Robert L Dixon JR | Director | Sell | −420 | −$208.80K |
| 2022-05-20 | Robert L Dixon JR | Director | A | +440 | — |
| 2022-05-20 | Bahija Jallal | Director | A | +440 | — |
| 2022-05-20 | Ryan M. Schneider | Director | A | +440 | — |
| 2022-05-20 | Elizabeth E Tallett | Director | A | +440 | — |
| 2022-05-20 | R Kerry Clark | Director | A | +440 | — |
| 2022-05-20 | Ramiro G Peru | Director | MIXED | −550 | −$464.19K |
| 2022-05-20 | Lewis Hay III | Director | A | +440 | — |
| 2022-05-20 | Susan D. DeVore | Director | A | +440 | — |
| 2022-05-20 | Antonio F Neri | Director | A | +440 | — |
| 2022-03-14 | Peter D Haytaian | EVP & Pres., DBG & IngenioRx | MIXED | −15,855 | −$7.91M |
| 2022-03-03 | Gail Boudreaux | President and CEO | MIXED | +19,501 | −$7.69M |
| 2022-03-03 | Felicia F Norwood | EVP & President, GBD | MIXED | +5,182 | −$1.82M |
| 2022-03-03 | Blair Williams Todt | EVP and Chief Legal Officer | MIXED | +1,692 | −$86.24K |
| 2022-03-03 | Peter D Haytaian | EVP & Pres., DBG & IngenioRx | MIXED | +5,305 | −$2.34M |
| 2022-03-03 | Charles Morgan Kendrick JR | EVP & President, Commercial | MIXED | +3,055 | −$413.99K |
| 2022-03-03 | Gloria M McCarthy | EVP & Chief Administrative Off | MIXED | +5,107 | −$2.42M |
| 2022-03-03 | John E Gallina | EVP & Chief Financial Officer | MIXED | +5,162 | −$2.07M |
| 2022-03-03 | Ronald W Penczek | CAO & Controller | MIXED | −110 | −$856.64K |
| 2022-02-08 | Ronald W Penczek | CAO & Controller | MIXED | — | −$538.73K |
| 2022-01-04 | Leah Stark | EVP & CHRO | F | −482 | −$225.17K |
| 2022-01-04 | Felicia F Norwood | EVP & President, GBD | F | −1,754 | −$819.38K |
| 2021-12-03 | Blair Williams Todt | EVP and Chief Legal Officer | F | −79 | −$31.97K |
| 2021-11-03 | Charles Morgan Kendrick JR | EVP & President, Commercial | A | +525 | — |
| 2021-11-03 | Peter D Haytaian | EVP & Pres., DBG & IngenioRx | A | +1,167 | — |
| 2021-10-29 | Ronald W Penczek | SVP, Chief Accounting Officer | Sell | −1,150 | −$501.40K |
| 2021-10-04 | Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | F | −311 | −$116.91K |
| 2021-09-08 | Prakash R Patel | EVP & President, DBG | F | −3,507 | −$1.32M |
| 2021-09-03 | Susan D. DeVore | Director | A | +416 | — |
| 2021-07-26 | Ryan M. Schneider | Director | Buy | +1,300 | +$499.67K |
| 2021-07-07 | Felicia F Norwood | EVP & President, GBD | F | −5,543 | −$2.15M |
| 2021-05-28 | Bahija Jallal | Director | A | +493 | — |
| 2021-05-28 | Lewis Hay III | Director | A | +493 | — |
| 2021-05-28 | Elizabeth E Tallett | Director | A | +493 | — |
| 2021-05-28 | Robert L Dixon JR | Director | A | +493 | — |
| 2021-05-28 | R Kerry Clark | Director | A | +493 | — |
| 2021-05-28 | Ramiro G Peru | Director | A | +493 | — |
| 2021-05-28 | Ryan M. Schneider | Director | A | +493 | — |
| 2021-05-28 | Antonio F Neri | Director | A | +493 | — |
| 2021-05-26 | John E Gallina | EVP & Chief Financial Officer | MIXED | −3,301 | −$9.95M |
| 2021-05-26 | Ramiro G Peru | Director | Sell | −1,308 | −$520.61K |
| 2021-05-24 | Robert L Dixon JR | Director | Sell | −590 | −$231.79K |
| 2021-05-24 | Julie A Hill | Director | Sell | −1,308 | −$515.35K |
| 2021-05-07 | Peter D Haytaian | EVP & President, Commercial | Sell | −1,000 | −$270.00K |
| 2021-03-23 | Peter D Haytaian | EVP & President, Commercial | MIXED | −21,407 | −$15.52M |
| 2021-03-08 | Ronald W Penczek | SVP, Chief Accounting Officer | Sell | −2,068 | −$690.59K |
| 2021-03-05 | Ronald W Penczek | SVP, Chief Accounting Officer | Sell | −67 | −$21.68K |
| 2021-03-03 | Peter D Haytaian | EVP & President, Commercial | MIXED | +11,309 | −$4.59M |
| 2021-03-03 | Felicia F Norwood | EVP & President, GBD | MIXED | +14,125 | −$160.78K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ANTM quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.